Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Cancers
|
June 19, 2024
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study
Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Cancers
|
August 5, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. <i>Cancers</i> 2024, <i>16</i>, 2097
Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Swiss Medical Weekly
|
September 8, 2021
Swiss germ-cell cancer consensus recommendations
Jörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
Revue Medicale Suisse
|
January 28, 2021
[2020 oncology update]
Giovanni Dei Tos, Ilianna Galli Vareia, Alexandre Huber, et al.
Lancet (London, England)
|
November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial
Adrien Rousseau, Maryam Karimi, Stefan Michiels, et al.
Revue Medicale Suisse
|
January 22, 2020
[Advances in Oncology 2019]
Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, et al.
Clinical Genitourinary Cancer
|
July 25, 2016
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program
Dimitrios Papazoglou, Luciano Wannesson, Dominik Berthold, et al.
Revue Medicale Suisse
|
December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Cancers
|
June 19, 2024
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study
Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Cancers
|
August 5, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. <i>Cancers</i> 2024, <i>16</i>, 2097
Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Swiss Medical Weekly
|
September 8, 2021
Swiss germ-cell cancer consensus recommendations
Jörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
Revue Medicale Suisse
|
January 28, 2021
[2020 oncology update]
Giovanni Dei Tos, Ilianna Galli Vareia, Alexandre Huber, et al.
Lancet (London, England)
|
November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial
Adrien Rousseau, Maryam Karimi, Stefan Michiels, et al.
Revue Medicale Suisse
|
January 22, 2020
[Advances in Oncology 2019]
Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, et al.
Clinical Genitourinary Cancer
|
July 25, 2016
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program
Dimitrios Papazoglou, Luciano Wannesson, Dominik Berthold, et al.
Revue Medicale Suisse
|
December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.
Page
of 4